Previous 10 | Next 10 |
Company to study OSCPeP device usage for active smokers and second-hand exposure Las Vegas, NV - ( NewMediaWire ) - January 27, 2022 - BioAdaptives, Inc. (OTCMkts: BDPT) announced today that it is commencing preliminary investigation into the clinical utilization of its Lung Armor&...
BioAdaptives to Acquire T J Mohr Patents and Other Potential Inventions Las Vegas, NV - ( NewMediaWire ) - January 20, 2022 - BioAdaptives, Inc. (OTCMkts: BDPT) announced today that it has entered into a Letter of Intent with inventor Thomas J. Mohr, to acquire rights to his U.S. Patent ...
Las Vegas, NV, Dec. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc. (OTCMkts: BDPT) announced that it has entered into a Marketing Agreement with Acoustic Innovations LLC, the developer of the LungFlute™ OscPEP (Oscillating Positive Expiratory Pressur...
PluriPain studied for pain relief in Gadolinium toxicity patients Las Vegas, NV - ( NewMediaWire ) - August 26, 2021 - BioAdaptives, Inc. (OTCMkts: BDPT) announced the collaboration with Professor Lorrin Koran, M.D., Stanford Medical Center, Stanford, CA. Dr. Edward Jacobs, ...
Marketing Initiative and Ambassador Program Las Vegas, NV - ( NewMediaWire ) - July 22, 2021 - BioAdaptives, Inc. (OTCMkts: BDPT) announced that its Livestock Impact Division, the marketer of Equine All-in-One™ and Canine Regen® products, has commenced an Ambassador Pr...
Targets 11 million Customers and E-Gamers Las Vegas, Nevada, June 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc. (OTCMkts: BDPT) announced a Licensing and Co-Marketing Agreement with The Fedr8tion Ltd., a UK-based software development and marketing c...
Townsend Appointed as COO and Director; Ellis Appointed as President and Director; Lambrecht Appointed as CFO Las Vegas, Nevada, June 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc. (OTCMkts: BDPT) announced the appointment of Charles Townsend as Chie...
Targets markets for pain relief and anti-viral/immune defense applications Las Vegas, Nevada, June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioAdaptives, Inc. (OTCMkts: BDPT) announced the kick-off of its social media outreach advertising campaign. J Ramsde...
Las Vegas, Nevada, Sept. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioAdaptives, Inc. (OTC BB: BDPT) announced the Company’s formation of TizHemp, a new operating division to concentrate efforts on wellness-related hemp-based products, and the appointment of Mr. Ron Lambrecht ...
LAS VEGAS, May 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC PINK:BDPT) announced Dr. James Rouse has been appointed to the board of Directors and accepted the position of President. He will start serving in both roles effective immediately. Dr. James, as he is fondly known, is a fun...
News, Short Squeeze, Breakout and More Instantly...
LAS VEGAS, NV, April 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the intention to spin off its Livestock Impact Division as a wholly-owned subsidiary. The new company will continue to develop and market natural suppleme...
Las Vegas, NV - ( NewMediaWire ) - April 18, 2023 - BioAdaptives, Inc. (OTCMkts: BDPT) announced today the signing of a non-exclusive license agreement with LY Research Corporation to market a patented resveratrol product (patent US # 6,855,353) for animals and humans. Edward Jacobs, M...
Las Vegas, NV - ( NewMediaWire ) - April 13, 2023 - BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment of David Allen, PhD to its Board of Directors. Edward Jacobs, M.D., CEO BioAdaptives, Inc., comments, “We are very pleased to be joined by David Allen, PhD on our Boa...